J. Goldman & Co’s NxStage Medical Inc. NXTM Stock Holding History

J. Goldman & Co’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,000	Closed	-$138K	–	487
2017 Q3	$138K	Buy	+5,000	New	+$133K	0.01%	316

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

J. Goldman & Co's NXTM Position: Q4 2017 in Review

J. Goldman & Co sold out of NxStage Medical Inc. (NXTM) in Q4 2017, closing a stake of 5,000 shares — an estimated $138K sold.

J. Goldman & Co first reported a position in NXTM in Q3 2017 and held it in 1 quarter. The position peaked at $138K in Q3 2017. 178 funds tracked by Wall St. Rank hold NXTM as of Q4 2017.

J. Goldman & Co reported no remaining NxStage Medical Inc. position as of Q4 2017 after selling out during the quarter.
J. Goldman & Co sold 5,000 NxStage Medical Inc. shares in Q4 2017, an estimated $138K.
J. Goldman & Co first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 1 quarter.
J. Goldman & Co's NxStage Medical Inc. position peaked at $138K in Q3 2017.
178 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2017.

Based on J. Goldman & Co's 13F filing for Q4 2017, filed 14 Feb 2018.